Related Experiment Videos
Early proximal tubular dysfunction in Lowe's syndrome
G F Laube1, I M Russell-Eggitt, W G van't Hoff
1Nephrourology Unit, Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.
Archives of Disease in Childhood
|April 23, 2004
Summary
Diagnosing Lowe syndrome in boys can be challenging. Increased urinary retinol binding protein (RBP) and N-acetyl-glucosaminidase (NAG) levels suggest this condition, aiding early detection.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Lowe syndrome, a rare genetic disorder, presents diagnostic challenges in early stages.
- Key biomarkers for Lowe syndrome require identification to improve diagnostic accuracy.
Purpose of the Study:
- To evaluate urinary retinol binding protein (RBP) and N-acetyl-glucosaminidase (NAG) as potential early diagnostic markers for Lowe syndrome.
- To establish the clinical utility of measuring RBP and NAG in suspected cases of Lowe syndrome.
Main Methods:
- Collected urine samples from boys diagnosed with Lowe syndrome and control groups.
- Quantified urinary excretion levels of RBP and NAG using established biochemical assays.
Main Results:
- Significantly elevated urinary RBP levels were observed in boys with Lowe syndrome compared to controls.
- Significantly elevated urinary NAG levels were also found in boys with Lowe syndrome.
- These biomarkers showed potential for differentiating Lowe syndrome from other conditions.
Conclusions:
- Urinary RBP and NAG are promising biomarkers for the early diagnosis of Lowe syndrome.
- Measurement of these urinary parameters is recommended for prompt identification in clinically suspected cases.
- Further research can validate these findings in larger, diverse populations.